US stocks fluctuate as traders weigh virus spike against advances in treatment

Lucas Jackson/Reuters
  • US stocks fluctuated as traders weighed another record spike in virus cases against advances in treatment.
  • On Thursday the US reported 63,200 new coronavirus cases, another record spike, according to data from Johns Hopkins University
  • Meanwhile, Gilead Sciences released clinical-trial data on Friday suggesting its remdesivir treatment reduced COVID-19 mortality risk by 62%.
  • Oil fell as the International Energy Agency said the increase in coronavirus cases could hurt the market recovery.
  • Read more on Business Insider.

US stocks fluctuated on Friday as traders weighed another record spike in virus cases against advances in treatment.

On Thursday the US reported 63,200 new coronavirus cases, another record spike, according to data from Johns Hopkins University. Florida, Texas, and California also reported record deaths due to the virus.

Meanwhile, Gilead Sciences released clinical-trial data on Friday suggesting its remdesivir treatment reduced COVID-19 mortality risk by 62%.

Here’s where US indexes stood shortly after the 9:30 a.m. ET market open on Friday:


Read more:
The top-ranked stock-picker in small companies has returned 13 times more than his peers this year. He breaks down the 5 little-known stocks he’s using to bet on the 5G and work-from-home revolutions.

Oil rose even as the International Energy Agency said the increase in coronavirus cases could hurt the market recovery.West Texas Intermediate crude rose as much as 0.5%, to $US38.54 per barrel. Brent crude, the international benchmark, climbed 0.5%, to $US42.56 per barrel, at intraday lows.

Next week, earnings season starts for US companies, which could test investor risk appetites.

“The second-quarter results are set to lay bare the pandemic’s impact to a greater extent compared to the previous quarter’s figures and this could prove to be one of Wall Street’s worst earnings seasons,” said Han Tan, market analyst at FXTM. “It remains to be seen whether market participants have the stomach to digest such despairing numbers.”


Read more:
A Wall Street expert breaks down how universal basic income would directly benefit 4 sectors of the stock market and squash wealth inequality – despite critics warning it would be a disaster

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.